IT1400236B1 - Impiego di composti noti per il trattamento dell'insufficienza renale cronica(irc) - Google Patents

Impiego di composti noti per il trattamento dell'insufficienza renale cronica(irc)

Info

Publication number
IT1400236B1
IT1400236B1 ITMI2010A000828A ITMI20100828A IT1400236B1 IT 1400236 B1 IT1400236 B1 IT 1400236B1 IT MI2010A000828 A ITMI2010A000828 A IT MI2010A000828A IT MI20100828 A ITMI20100828 A IT MI20100828A IT 1400236 B1 IT1400236 B1 IT 1400236B1
Authority
IT
Italy
Prior art keywords
irc
treatment
known compounds
chronic kidney
kidney failure
Prior art date
Application number
ITMI2010A000828A
Other languages
English (en)
Inventor
Giuseppe Castellano
Francesco Paolo Schena
Original Assignee
Univ Bari
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Bari filed Critical Univ Bari
Priority to ITMI2010A000828A priority Critical patent/IT1400236B1/it
Priority to EP11727516A priority patent/EP2568998A1/en
Priority to PCT/IB2011/000956 priority patent/WO2011141787A1/en
Publication of ITMI20100828A1 publication Critical patent/ITMI20100828A1/it
Application granted granted Critical
Publication of IT1400236B1 publication Critical patent/IT1400236B1/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A61K38/212—IFN-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ITMI2010A000828A 2010-05-10 2010-05-10 Impiego di composti noti per il trattamento dell'insufficienza renale cronica(irc) IT1400236B1 (it)

Priority Applications (3)

Application Number Priority Date Filing Date Title
ITMI2010A000828A IT1400236B1 (it) 2010-05-10 2010-05-10 Impiego di composti noti per il trattamento dell'insufficienza renale cronica(irc)
EP11727516A EP2568998A1 (en) 2010-05-10 2011-05-06 Use of interferon alpha for the treatment of chronic kidney disease
PCT/IB2011/000956 WO2011141787A1 (en) 2010-05-10 2011-05-06 Use of interferon alpha for the treatment of chronic kidney disease

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITMI2010A000828A IT1400236B1 (it) 2010-05-10 2010-05-10 Impiego di composti noti per il trattamento dell'insufficienza renale cronica(irc)

Publications (2)

Publication Number Publication Date
ITMI20100828A1 ITMI20100828A1 (it) 2011-11-11
IT1400236B1 true IT1400236B1 (it) 2013-05-24

Family

ID=43304916

Family Applications (1)

Application Number Title Priority Date Filing Date
ITMI2010A000828A IT1400236B1 (it) 2010-05-10 2010-05-10 Impiego di composti noti per il trattamento dell'insufficienza renale cronica(irc)

Country Status (3)

Country Link
EP (1) EP2568998A1 (it)
IT (1) IT1400236B1 (it)
WO (1) WO2011141787A1 (it)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201621728D0 (en) 2016-12-20 2017-02-01 Ucb Biopharma Sprl Methods

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003031587A2 (en) * 2001-10-09 2003-04-17 The Regents Of The University Of California Use of stat-6 inhibitors as therapeutic agents
WO2005067963A1 (en) * 2003-12-23 2005-07-28 Intermune, Inc. Use of polyethylene glycol-modified interferon-alpha in therapeutic dosing regimens
US20080260820A1 (en) * 2007-04-19 2008-10-23 Gilles Borrelly Oral dosage formulations of protease-resistant polypeptides

Also Published As

Publication number Publication date
WO2011141787A1 (en) 2011-11-17
ITMI20100828A1 (it) 2011-11-11
EP2568998A1 (en) 2013-03-20

Similar Documents

Publication Publication Date Title
LTPA2020510I1 (lt) Pakeistieji 4-fenil-piridinai, skirti su NK-receptoriumi susijusių ligų gydymui
DK2504005T3 (da) Anvendelse af 1,3-diphenylprop-2-en-1-on-derivater til behandling af lever-sygdomme
SMAP200900085A (it) 3-imidazolil-indoli per il trattamento di malattieproliferative
CO6890103A2 (es) Compuestos sustituidos fungicidas de 2-[2-halogenalquil-4-(fenoxi)-fenil]-1-[1,2,4]triazol-1-il-etanol
DK2919796T3 (da) Brug af akkermansia til behandling af stofskiftesygdomme
GB201021103D0 (en) New compounds for the treatment of neurodegenerative diseases
ZA201401678B (en) Novel distributed 3,4-diamino-cyclobutene-1,2-dione compounds for use in the treatment of chemokine-mediated diseases
FR2973218B1 (fr) Plaque d'osteosynthese.
HK1198947A1 (en) Thromboembolism preventive therapeutic agent for thromboembolism patients having severe renal dysfunction
EE201300004A (et) Kombineeritud ravimkoostis sdame-veresoonkonnaga seotud haiguste v?i seisundite raviks
SMT201700081B (it) Agenti terapeutici per la regolazione del fosforo sierico
BR112013014966A2 (pt) composto aricíclico contínuo
IT1406864B1 (it) Composizione per il trattamento dell'acne
BR112014001425A2 (pt) forma de dosagem farmacêutica, composição farmacêutica, e, composto (i) ou sal farmaceuticamente aceitável do mesmo
IT1403587B1 (it) Composizione per il trattamento di disordini metabolici
SMT201600479B (it) Nuove soluzioni terapeutiche per il trattamento di condizioni neuroinfiammatorie
ITMI20080195A1 (it) Procedimento per la preparazione di solifenacin
ITMI20072141A1 (it) Procedimento per la preparazione del drospirenone
IT1405996B1 (it) Procedimento per la preparazione di 2,5-diaminotoluolo
FR2971413B1 (fr) Vis a usage medical, notamment pour la realisation d'une osteosynthese
IT1400710B1 (it) Procedimento per l'ossidazione di idrocarburi alchilaromatici catalizzata da n-idrossiderivati
SMT201300156B (it) Composti solfonammidici per il trattamento di disturbi respiratori
ITRM20080037A1 (it) Procedimento per la ultrapurificazione di alginati.
IT1400236B1 (it) Impiego di composti noti per il trattamento dell'insufficienza renale cronica(irc)
ITMI20110184A1 (it) Composti fotosensibilizzanti "metal free"